Dr Grace MortensonAssociate Principal Scientist at Merck Research LabsSpeaker
Profile
Grace completed her Ph.D. in Chemistry at the University of Wisconsin-Madison and worked on elucidating the structure-function relationship of ubiquitin-proteosome signaling pathways. Before joining Merck Discovery Biologics in 2017, she was a post-doctoral researcher at the Novartis Institute of Functional Genomics in San Diego, CA and worked on developing conjugation and modality technologies for novel antibody drug conjugates. At Merck, she is a member of the protein engineering team and works on innovating and developing biotherapeutics for oncology and immunology indications.
Agenda Sessions
uPAR Targeting Cytotoxic Antibody Drug Conjugates Selectively Deplete Proinflammatory Myeloid Cells for Autoimmune Indications
, 4:45pmView Session
